National registry for chronic itch patients
Official title: Swiss Itch Registry (SWITCHR) - A Prospective Registry to Collect Data of Patients With Chronic Pruritus
Run by University Hospital, Basel, Switzerland · NCT06120907 · Data updated 2026-11-12
This study is creating a national registry for people in Switzerland with chronic itching to better understand their needs and improve treatment options.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 14 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University Hospital, Basel, Switzerland Academic / other |
| Locations | 1 site (Basel) |
| Status | Recruiting |
| Started | October 18, 2023 |
| Main results expected | October 2033 |
| Study ends | October 2033 |
| Registry record updated | December 13, 2024 |
| Trial ID | NCT06120907 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this registry are individuals aged 14 and older with a diagnosis of chronic pruritus and a minimum itch severity score.
✕Probably not a fit
Patients with conditions that prevent them from participating in the registry or those who refuse to complete necessary assessments may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project aims to establish a national registry for patients suffering from chronic pruritus (itch) in Switzerland. Participants will undergo comprehensive assessments including patient-reported outcomes, physician evaluations, blood tests, and imaging techniques at specified intervals. The registry will facilitate a better understanding of patient needs, treatment outcomes, and safety issues related to chronic pruritus. Additionally, it will enable standardized comparisons of various pruritic conditions and enhance awareness among healthcare providers and authorities.
Why it matters
Potential benefit: If successful, this registry could significantly improve the management and treatment of chronic pruritus, leading to better patient outcomes.
How similar studies have gone: While this approach is novel in Switzerland, similar registries have shown success in other countries, indicating potential for impactful outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 14 years. * Written informed consent of the patient. * Diagnosis of CP irrespective of the International Forum for the Study of Itch (IFSI) group (I-III) and/or underlying cause (according to the judgment of the investigator). * A Numerical Rating Scale (NRS) score of min. ≥ 4 within the last 7 days. * Sufficient language skills (in the languages which the patient information and the consent form is available) to provide informed consent. Exclusion Criteria: * Any medical or psychological condition in the treating physician's opinion, which may prevent the patient in registry participation * Lack of informed consent for registry participation. * Refusal to complete Patient Reported Outcomes (PROs)
Where it's running
-
Department of Dermatology, University Hospital Basel
Basel, Switzerland Recruiting
Study contacts
- Principal investigator: Simon Mueller, PD Dr. med. — Department of Dermatology, University Hospital Basel
- Study coordinator: Simon Mueller, PD Dr. med.
- Email: simon.mueller@usb.ch
- Phone: +41 61 328 69 64
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Nocturnal ScratchSense ring: test of automatic scratch detection in adults with itchy skin
This study tests whether the Replior ScratchSense ring can accurately detect and measure nighttime scratching in adults with itchy skin conditions.
-
VR-enhanced progressive muscle relaxation for chronic symptoms after burn injury
This will try progressive muscle relaxation with and without virtual reality to see if it helps adult burn survivors reduce chronic pain, itch, anxiety, sleep problems, or fatigue.
-
Using Virtual Reality and Hypnosis to Reduce Chronic Itch
This study is testing whether using virtual reality combined with hypnosis can help people with chronic itch feel better.
-
Using cervical traction to reduce medication for neuropathic itch
This study is testing whether cervical traction can help people with neuropathic itch reduce their need for medications like gabapentin or pregabalin.
-
Evaluating the safety of difelikefalin for itchy skin in adolescents on dialysis
This study is testing if a new medication called difelikefalin can safely help relieve itching in teenagers aged 12 to 17 who are on dialysis for kidney disease.
-
Understanding itching caused by drug-induced liver injury
This study looks at how common itching is for people with drug-induced liver injury to better understand it and help find new treatments.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.